Literature DB >> 16930849

Injection drug users' perceptions regarding use of a medically supervised safer injecting facility.

Steven Petrar1, Thomas Kerr, Mark W Tyndall, Ruth Zhang, Julio S G Montaner, Evan Wood.   

Abstract

BACKGROUND: In recent years, there has been increased interest in supervised safer injecting facilities (SIF) as a strategy to reduce the harms of illicit drug use; however, little work has been done to assess drug users' satisfaction with this service. This study was undertaken to explore injection drug users' experiences and opinions regarding North America's first SIF in Vancouver, Canada.
METHODS: Injection drug users (IDU) were randomly recruited from within the Vancouver SIF and invited to enroll in the Scientific Evaluation of Supervised Injecting (SEOSI) cohort. For the present study, participants were then surveyed regarding their experiences and beliefs regarding the SIF.
RESULTS: Of 1082 IDU surveyed, 809 (75%) reported that their injecting behavior had changed as a result of using the SIF. Among these individuals, 80% indicated that the SIF had resulted in less rushed injecting, 71% indicated that the SIF had led to less outdoor injecting and 56% reported less unsafe syringe disposal. The three most common features always or usually limiting IDU's use of the SIF were: travel to the SIF (12%), limited operating hours (7%), and waiting times to access the SIF (5%). When asked in what ways the SIF might be improved, the three most common suggestions were: longer hours of operation (53%), addition of a washroom (51%), and reduced waiting times (46%).
CONCLUSIONS: Many IDU reported changes in their injecting behaviors that have important implications for community and public health. Addressing a number of programmatic issues related to operating hours and waiting times, and the provision of additional amenities within SIF, may help to further improve their impact.

Entities:  

Mesh:

Year:  2006        PMID: 16930849     DOI: 10.1016/j.addbeh.2006.07.013

Source DB:  PubMed          Journal:  Addict Behav        ISSN: 0306-4603            Impact factor:   3.913


  28 in total

1.  The validity of reporting willingness to use a supervised injecting facility on subsequent program use among people who use injection drugs.

Authors:  Kora DeBeck; Thomas Kerr; Calvin Lai; Jane Buxton; Julio Montaner; Evan Wood
Journal:  Am J Drug Alcohol Abuse       Date:  2011-08-11       Impact factor: 3.829

2.  Summary of findings from the evaluation of a pilot medically supervised safer injecting facility.

Authors:  Evan Wood; Mark W Tyndall; Julio S Montaner; Thomas Kerr
Journal:  CMAJ       Date:  2006-11-21       Impact factor: 8.262

3.  Negotiating place and gendered violence in Canada's largest open drug scene.

Authors:  Ryan McNeil; Kate Shannon; Laura Shaver; Thomas Kerr; Will Small
Journal:  Int J Drug Policy       Date:  2013-11-22

Review 4.  Public Health and Public Order Outcomes Associated with Supervised Drug Consumption Facilities: a Systematic Review.

Authors:  Mary Clare Kennedy; Mohammad Karamouzian; Thomas Kerr
Journal:  Curr HIV/AIDS Rep       Date:  2017-10       Impact factor: 5.071

Review 5.  Opioid use disorder.

Authors:  John Strang; Nora D Volkow; Louisa Degenhardt; Matthew Hickman; Kimberly Johnson; George F Koob; Brandon D L Marshall; Mark Tyndall; Sharon L Walsh
Journal:  Nat Rev Dis Primers       Date:  2020-01-09       Impact factor: 52.329

6.  Supervised Injection Facility Utilization Patterns: A Prospective Cohort Study in Vancouver, Canada.

Authors:  Mary Clare Kennedy; David C Klassen; Huiru Dong; M-J S Milloy; Kanna Hayashi; Thomas H Kerr
Journal:  Am J Prev Med       Date:  2019-08-01       Impact factor: 5.043

7.  Perspectives on supervised injection facilities among service industry employees in New York City: A qualitative exploration.

Authors:  Brett Wolfson-Stofko; Luther Elliott; Alex S Bennett; Ric Curtis; Marya Gwadz
Journal:  Int J Drug Policy       Date:  2018-10-22

8.  Policing space in the overdose crisis: A rapid ethnographic study of the impact of law enforcement practices on the effectiveness of overdose prevention sites.

Authors:  Alexandra B Collins; Jade Boyd; Samara Mayer; Al Fowler; Mary Clare Kennedy; Ricky N Bluthenthal; Thomas Kerr; Ryan McNeil
Journal:  Int J Drug Policy       Date:  2019-09-18

Review 9.  The role of safer injection facilities in the response to HIV/AIDS among injection drug users.

Authors:  Thomas Kerr; Jo Kimber; Kora Debeck; Evan Wood
Journal:  Curr HIV/AIDS Rep       Date:  2007-12       Impact factor: 5.071

10.  Fighting addiction's death row: British Columbia Supreme Court Justice Ian Pitfield shows a measure of legal courage.

Authors:  Dan Small
Journal:  Harm Reduct J       Date:  2008-10-28
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.